BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 25412955)

  • 1. Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis.
    Starska K; Forma E; Jóźwiak P; Bryś M; Lewy-Trenda I; Brzezińska-Błaszczyk E; Krześlak A
    Tumour Biol; 2015 Apr; 36(4):2309-21. PubMed ID: 25412955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of hypoxia inducible factor-1α and correlated target genes in human laryngeal carcinoma].
    XU O; LI XM; WANG MX; QU YT; LU XY; SHAN CG; SUN QJ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 47(4):330-3. PubMed ID: 22800355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of HIF-1α and COX-2 expression in tumor stroma and correlation with the degree of neoplasm invasiveness in laryngeal cancer--preliminary study].
    Woś J; Bryś M; Lewy-Trenda I; Stasikowska O; Papież P; Papierz W; Starska K
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):102-8. PubMed ID: 22000259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of hypoxia-inducible factor-1 alpha reduces proliferation, induces apoptosis and attenuates the aggressive phenotype of retinoblastoma WERI-Rb-1 cells under hypoxic conditions.
    Xia T; Cheng H; Zhu Y
    Ann Clin Lab Sci; 2014; 44(2):134-44. PubMed ID: 24795051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT.
    Shen LF; Zhao X; Zhou SH; Lu ZJ; Zhao K; Fan J; Zhou ML
    Oncotarget; 2017 May; 8(21):34709-34726. PubMed ID: 28410229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and significance of hypoxia-inducible factor-1α and survivin in laryngeal carcinoma tissue and cells.
    Li DW; Zhou L; Jin B; Xie J; Dong P
    Otolaryngol Head Neck Surg; 2013 Jan; 148(1):75-81. PubMed ID: 23087365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
    Zhou JT; Cai ZM; Li NC; Na YQ
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas.
    Yamada T; Uchida M; Kwang-Lee K; Kitamura N; Yoshimura T; Sasabe E; Yamamoto T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Apr; 113(4):464-71. PubMed ID: 22676927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers.
    Bobarykina AY; Minchenko DO; Opentanova IL; Moenner M; Caro J; Esumi H; Minchenko OH
    Acta Biochim Pol; 2006; 53(4):789-99. PubMed ID: 17143338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
    Lim CS; Kiriakidis S; Paleolog EM; Davies AH
    J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
    Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU
    Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of lentiviral vector-mediated RNA interference targeting hypoxia-inducible factor 1α on the uptake of fluorodeoxyglucose ((18)f) in the human pancreatic cancer cell line, patu8988.
    Fan G; Bo J; Wan R; Peng M; Luan Y; Deng M; Xu L
    Cancer Biother Radiopharm; 2015 May; 30(4):160-8. PubMed ID: 25853522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of hypoxia-related glucose transporters GLUT1 and GLUT3 in benign, malignant and non-neoplastic thyroid lesions.
    Jóźwiak P; Krześlak A; Pomorski L; Lipińska A
    Mol Med Rep; 2012 Sep; 6(3):601-6. PubMed ID: 22752218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer.
    Starska K; Forma E; Lewy-Trenda I; Stasikowska-Kanicka O; Skóra M; Bryś M
    Cell Oncol (Dordr); 2018 Jun; 41(3):253-268. PubMed ID: 29299828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of Hypoxia-Inducible Factor-1α and Glucose Transporter-1 in Human Tongue Cancers.
    Vasconcelos MG; Vasconcelos RG; Pereira de Oliveira DH; de Moura Santos E; Pinto LP; da Silveira ÉJ; Queiroz LM
    J Oral Maxillofac Surg; 2015 Sep; 73(9):1753-60. PubMed ID: 25863229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of glucose transporters GLUT-1, GLUT-3, GLUT-9 and HIF-1alpha in normal and degenerate human intervertebral disc.
    Richardson SM; Knowles R; Tyler J; Mobasheri A; Hoyland JA
    Histochem Cell Biol; 2008 Apr; 129(4):503-11. PubMed ID: 18172662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation between hypoxia-inducible factor (HIF)-1alpha expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer.
    Cabanillas R; Rodrigo JP; Secades P; Astudillo A; Nieto CS; Chiara MD
    J Surg Oncol; 2009 May; 99(6):373-8. PubMed ID: 19226532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of hypoxia-inducible factor 1α, glucose transporter 1, and hexokinase 2 in primary central nervous system lymphoma and the correlation with the biological behaviors.
    Shen N; Wang Y; Sun X; Bai X; He J; Cui Q; Qian J; Zhu H; Chen Y; Xing R; Liu Q; Wu Y; Li J; Lai W; Sun S; Ji N; Liu Y
    Brain Behav; 2020 Aug; 10(8):e01718. PubMed ID: 32533646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
    Eckert AW; Lautner MH; Schütze A; Taubert H; Schubert J; Bilkenroth U
    Histopathology; 2011 Jun; 58(7):1136-47. PubMed ID: 21438910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.